Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Intercell AG |
---|---|
Information provided by: | Intercell AG |
ClinicalTrials.gov Identifier: | NCT00595790 |
The study investigates a rapid immunization regime of the Japanese Encephalitis vaccine IC51 (JE-PIV) in healthy subjects aged > or = 18 years
Condition | Intervention | Phase |
---|---|---|
Japanese Encephalitis |
Biological: Japanese Encephalitis purified inactivated vaccine |
Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Single Blind (Subject), Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Intercell AG |
Study ID Numbers: | IC51-304 |
Study First Received: | January 4, 2008 |
Last Updated: | January 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00595790 |
Health Authority: | United States: Food and Drug Administration |
Virus Diseases Japanese encephalitis Central Nervous System Infections Central Nervous System Diseases |
Encephalitis, Japanese Arbovirus Infections Brain Diseases Encephalitis |
Encephalitis, Viral RNA Virus Infections Flaviviridae Infections Flavivirus Infections |
Nervous System Diseases Central Nervous System Viral Diseases Encephalitis, Arbovirus |